List of Tables
Table 1. Dermatology OTC Drug Market Trends
Table 2. Dermatology OTC Drug Market Drivers & Opportunity
Table 3. Dermatology OTC Drug Market Challenges
Table 4. Dermatology OTC Drug Market Restraints
Table 5. Global Dermatology OTC Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Dermatology OTC Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Dermatology OTC Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Dermatology OTC Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Dermatology OTC Drug
Table 10. Global Dermatology OTC Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Dermatology OTC Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Dermatology OTC Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Dermatology OTC Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Dermatology OTC Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Dermatology OTC Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Dermatology OTC Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Dermatology OTC Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Dermatology OTC Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Dermatology OTC Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Dermatology OTC Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Dermatology OTC Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Dermatology OTC Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Dermatology OTC Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Dermatology OTC Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Dermatology OTC Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Dermatology OTC Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Dermatology OTC Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Dermatology OTC Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Bayer Basic Information List
Table 32. Bayer Description and Business Overview
Table 33. Bayer Dermatology OTC Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Dermatology OTC Drug Business of Bayer (2019-2024)
Table 35. Bayer Recent Developments
Table 36. GSK Basic Information List
Table 37. GSK Description and Business Overview
Table 38. GSK Dermatology OTC Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Dermatology OTC Drug Business of GSK (2019-2024)
Table 40. GSK Recent Developments
Table 41. Teva Basic Information List
Table 42. Teva Description and Business Overview
Table 43. Teva Dermatology OTC Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Dermatology OTC Drug Business of Teva (2019-2024)
Table 45. Teva Recent Developments
Table 46. Johnson & Johnson Basic Information List
Table 47. Johnson & Johnson Description and Business Overview
Table 48. Johnson & Johnson Dermatology OTC Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Dermatology OTC Drug Business of Johnson & Johnson (2019-2024)
Table 50. Johnson & Johnson Recent Developments
Table 51. Novartis Basic Information List
Table 52. Novartis Description and Business Overview
Table 53. Novartis Dermatology OTC Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Dermatology OTC Drug Business of Novartis (2019-2024)
Table 55. Novartis Recent Developments
Table 56. Viatris Basic Information List
Table 57. Viatris Description and Business Overview
Table 58. Viatris Dermatology OTC Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Dermatology OTC Drug Business of Viatris (2019-2024)
Table 60. Viatris Recent Developments
Table 61. Sun Pharmaceutical Basic Information List
Table 62. Sun Pharmaceutical Description and Business Overview
Table 63. Sun Pharmaceutical Dermatology OTC Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Dermatology OTC Drug Business of Sun Pharmaceutical (2019-2024)
Table 65. Sun Pharmaceutical Recent Developments
Table 66. Aurobindo Basic Information List
Table 67. Aurobindo Description and Business Overview
Table 68. Aurobindo Dermatology OTC Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Dermatology OTC Drug Business of Aurobindo (2019-2024)
Table 70. Aurobindo Recent Developments
Table 71. Galderma Basic Information List
Table 72. Galderma Description and Business Overview
Table 73. Galderma Dermatology OTC Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Dermatology OTC Drug Business of Galderma (2019-2024)
Table 75. Galderma Recent Developments
Table 76. CR SANJIU Basic Information List
Table 77. CR SANJIU Description and Business Overview
Table 78. CR SANJIU Dermatology OTC Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Dermatology OTC Drug Business of CR SANJIU (2019-2024)
Table 80. CR SANJIU Recent Developments
Table 81. Dr. Reddy's Basic Information List
Table 82. Dr. Reddy's Description and Business Overview
Table 83. Dr. Reddy's Dermatology OTC Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Dermatology OTC Drug Business of Dr. Reddy's (2019-2024)
Table 85. Dr. Reddy's Recent Developments
Table 86. Lupin Basic Information List
Table 87. Lupin Description and Business Overview
Table 88. Lupin Dermatology OTC Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Dermatology OTC Drug Business of Lupin (2019-2024)
Table 90. Lupin Recent Developments
Table 91. Bausch Health Basic Information List
Table 92. Bausch Health Description and Business Overview
Table 93. Bausch Health Dermatology OTC Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Dermatology OTC Drug Business of Bausch Health (2019-2024)
Table 95. Bausch Health Recent Developments
Table 96. Cipla Basic Information List
Table 97. Cipla Description and Business Overview
Table 98. Cipla Dermatology OTC Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Dermatology OTC Drug Business of Cipla (2019-2024)
Table 100. Cipla Recent Developments
Table 101. Livzon Basic Information List
Table 102. Livzon Description and Business Overview
Table 103. Livzon Dermatology OTC Drug Products, Services and Solutions
Table 104. Revenue (US$ Million) in Dermatology OTC Drug Business of Livzon (2019-2024)
Table 105. Livzon Recent Developments
Table 106. Almirall Basic Information List
Table 107. Almirall Description and Business Overview
Table 108. Almirall Dermatology OTC Drug Products, Services and Solutions
Table 109. Revenue (US$ Million) in Dermatology OTC Drug Business of Almirall (2019-2024)
Table 110. Almirall Recent Developments
Table 111. Lingrui Basic Information List
Table 112. Lingrui Description and Business Overview
Table 113. Lingrui Dermatology OTC Drug Products, Services and Solutions
Table 114. Revenue (US$ Million) in Dermatology OTC Drug Business of Lingrui (2019-2024)
Table 115. Lingrui Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Dermatology OTC Drug Downstream Customers
Table 119. Dermatology OTC Drug Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Dermatology OTC Drug Product Picture
Figure 2. Global Dermatology OTC Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Dermatology OTC Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Dermatology OTC Drug Report Years Considered
Figure 5. Global Dermatology OTC Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Dermatology OTC Drug Revenue in 2023
Figure 7. Dermatology OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Antifungals Medication Picture
Figure 9. Skin Disinfection Medication Picture
Figure 10. Skin Irritation Medication Picture
Figure 11. Wounds and Herpes Simplex Medication Picture
Figure 12. Anti-Psoriasis Medication Picture
Figure 13. Other Picture
Figure 14. Global Dermatology OTC Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Dermatology OTC Drug Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Drug Store
Figure 18. Product Picture of Other
Figure 19. Global Dermatology OTC Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Dermatology OTC Drug Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Dermatology OTC Drug Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Dermatology OTC Drug Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Dermatology OTC Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Dermatology OTC Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Dermatology OTC Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Dermatology OTC Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Dermatology OTC Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Dermatology OTC Drug Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Dermatology OTC Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Dermatology OTC Drug Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Dermatology OTC Drug Sales Value (%), (2019-2030)
Figure 32. United States Dermatology OTC Drug Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Dermatology OTC Drug Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Dermatology OTC Drug Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Dermatology OTC Drug Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Dermatology OTC Drug Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Dermatology OTC Drug Sales Value by Application (%), 2023 VS 2030
Figure 38. China Dermatology OTC Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Dermatology OTC Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. China Dermatology OTC Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Dermatology OTC Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Dermatology OTC Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Dermatology OTC Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Dermatology OTC Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Dermatology OTC Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Dermatology OTC Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Dermatology OTC Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Dermatology OTC Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Dermatology OTC Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. India Dermatology OTC Drug Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Dermatology OTC Drug Sales Value by Type (%), 2023 VS 2030
Figure 52. India Dermatology OTC Drug Sales Value by Application (%), 2023 VS 2030
Figure 53. Dermatology OTC Drug Industrial Chain
Figure 54. Dermatology OTC Drug Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
